CTOs on the Move

Arrowhead Pharmaceuticals

www.arrowheadpharma.com

 
Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for ...
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details
Scott Phillips
Director, Enterprise Systems and Compliance Profile

Funding

Arrowhead Pharmaceuticals raised $45M on 08/13/2016
Arrowhead Pharmaceuticals raised $45M on 08/16/2016

Similar Companies

Essential Formulas

Essential Formulas is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hoechst AG

Hoechst AG is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OVP HEALTH

HEALTHIER. COMMUNITY. OVP HEALTH provides an extensive range of addiction treatment services, emergency department and hospitalist staffing and management services.

Zogenix

Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.

DM Clinical Research

DM Clinical Research is a clinical research company that connects pharmaceutical and research organizations to individuals seeking to power the advancement of medicine. They specialize in multiple therapeutic areas in Phase I-IV clinical trials.